Gene · 1491
Papers3,417
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,417
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CSE/H2S ameliorates colitis in mice via protection of enteric glial cells and inhibition of the RhoA/ROCK pathway. | Front Immunol | 2022 | 36189321 | PubTator, text mining | PubMed |
| Co-administration of sodium hydrosulfide and tadalafil modulates hypoxia and oxidative stress on bladder dysfunction in a rat model of bladder outlet obstruction. | Int Braz J Urol | 2022 | 36173409 | PubTator, text mining | PubMed |
| Therapeutic implications of mitochondrial stress-induced proteasome inhibitor resistance in multiple myeloma. | Sci Adv | 2022 | 36170375 | PubTator, text mining | PubMed |
| Serum Homocysteine and Vascular Calcification: Advances in Mechanisms, Related Diseases, and Nutrition. | Korean J Fam Med | 2022 | 36168899 | PubTator, text mining | PubMed |
| FBXW7 Reduces the Cancer Stem Cell-Like Properties of Hepatocellular Carcinoma by Regulating the Ubiquitination and Degradation of ACTL6A. | Stem Cells Int | 2022 | 36159747 | PubTator, text mining | PubMed |
| Does Methionine Status Influence the Outcome of Selenomethinione Supplementation? A Comparative Study of Metabolic and Selenium Levels in HepG2 Cells. | Nutrients | 2022 | 36145081 | PubTator, text mining | PubMed |
| The Effects of H2S and Recombinant Human Hsp70 on Inflammation Induced by SARS and Other Agents In Vitro and In Vivo. | Biomedicines | 2022 | 36140256 | PubTator, text mining | PubMed |
| Sequential Accumulation of 'Driver' Pathway Mutations Induces the Upregulation of Hydrogen-Sulfide-Producing Enzymes in Human Colonic Epithelial Cell Organoids. | Antioxidants (Basel) | 2022 | 36139896 | PubTator, text mining | PubMed |
| Recent Development of the Molecular and Cellular Mechanisms of Hydrogen Sulfide Gasotransmitter. | Antioxidants (Basel) | 2022 | 36139861 | PubTator, text mining | PubMed |
| Dysregulated Sulfide Metabolism in Multiple Sclerosis: Serum and Vascular Endothelial Inflammatory Responses. | Pathophysiology | 2022 | 36136071 | PubTator, text mining | PubMed |
| Gasotransmitter H2S accelerates seed germination via activating AOX mediated cyanide-resistant respiration pathway. | Plant Physiol Biochem | 2022 | 36126464 | PubTator, text mining | PubMed |
| Development of Hydrogen Sulfide-Releasing Carbonic Anhydrases IX- and XII-Selective Inhibitors with Enhanced Antihyperalgesic Action in a Rat Model of Arthritis. | J Med Chem | 2022 | 36121705 | PubTator, text mining | PubMed |
| Subcellular Delivery of Hydrogen Sulfide Using Small Molecule Donors Impacts Organelle Stress. | J Am Chem Soc | 2022 | 36121306 | PubTator, text mining | PubMed |
| Regulation of CyR61 expression and release by 3-mercaptopyruvate sulfurtransferase in colon cancer cells. | Redox Biol | 2022 | 36113340 | PubTator, text mining | PubMed |
| Hydrogen sulfide donor GYY4137 attenuates vascular complications in mesenteric bed of streptozotocin-induced diabetic rats. | Eur J Pharmacol | 2022 | 36108734 | PubTator, text mining | PubMed |
| System Xc -/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. | Front Pharmacol | 2022 | 36105219 | PubTator, text mining | PubMed |
| Editorial: Impaired oxygen delivery in experimental disease models: Pathogenesis, diagnostics and treatment strategies. | Front Med (Lausanne) | 2022 | 36091701 | PubTator, text mining | PubMed |
| Current progress of ferroptosis study in ovarian cancer. | Front Mol Biosci | 2022 | 36090052 | PubTator, text mining | PubMed |
| Cystathionine β-synthase as novel endogenous regulator of lymphangiogenesis via modulating VEGF receptor 2 and 3. | Commun Biol | 2022 | 36088423 | PubTator, text mining | PubMed |
| Characterization of human cystathionine γ-lyase enzyme activities toward d-amino acids. | Biosci Biotechnol Biochem | 2022 | 36085174 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1491/papers?page=26